A low repair endotype is predictive for response to FGF-18 treatment: data from the phase II oa forward study. (April 2021) - Bay-Jensen, A.-C; Manginelli, A.; Karsdal, M.A.; Luo, Y.; He, Y.; Michaelis, M.; Guehring, H.; Ladel, C.